PTC Therapeutics Inc (PTCT)
30.58
-4.08
(-11.77%)
USD |
NASDAQ |
Jun 28, 16:00
30.51
-0.07
(-0.23%)
After-Hours: 20:00
PTC Therapeutics SG&A Expense (TTM): 318.90M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 318.90M |
December 31, 2023 | 332.54M |
September 30, 2023 | 348.97M |
June 30, 2023 | 348.20M |
March 31, 2023 | 339.64M |
December 31, 2022 | 326.00M |
September 30, 2022 | 319.83M |
June 30, 2022 | 308.96M |
March 31, 2022 | 297.95M |
December 31, 2021 | 285.77M |
September 30, 2021 | 274.68M |
June 30, 2021 | 263.27M |
March 31, 2021 | 248.05M |
December 31, 2020 | 245.16M |
September 30, 2020 | 233.20M |
June 30, 2020 | 224.65M |
March 31, 2020 | 220.20M |
December 31, 2019 | 202.54M |
September 30, 2019 | 187.71M |
June 30, 2019 | 176.79M |
March 31, 2019 | 161.12M |
December 31, 2018 | 153.55M |
September 30, 2018 | 140.36M |
Date | Value |
---|---|
June 30, 2018 | 133.42M |
March 31, 2018 | 128.74M |
December 31, 2017 | 121.27M |
September 30, 2017 | 109.96M |
June 30, 2017 | 102.19M |
March 31, 2017 | 96.69M |
December 31, 2016 | 97.13M |
September 30, 2016 | 98.84M |
June 30, 2016 | 96.56M |
March 31, 2016 | 90.40M |
December 31, 2015 | 82.08M |
September 30, 2015 | 74.21M |
June 30, 2015 | 63.37M |
March 31, 2015 | 54.90M |
December 31, 2014 | 44.82M |
September 30, 2014 | 34.29M |
June 30, 2014 | 30.44M |
March 31, 2014 | 28.30M |
December 31, 2013 | 25.22M |
September 30, 2013 | 20.96M |
June 30, 2013 | 18.06M |
March 31, 2013 | 14.63M |
December 31, 2012 | 14.62M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
187.71M
Minimum
Sep 2019
348.97M
Maximum
Sep 2023
280.33M
Average
285.77M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
Biogen Inc | 2.526B |
Pfizer Inc | 14.85B |
Catalyst Pharmaceuticals Inc | 150.93M |
Ionis Pharmaceuticals Inc | 239.74M |
Sarepta Therapeutics Inc | 498.16M |